{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:51:21Z","timestamp":1790650281625,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201300015I"],"award-info":[{"award-number":["HHSN272201300015I"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272200800003C"],"award-info":[{"award-number":["HHSN272200800003C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5-20040-S1"],"award-info":[{"award-number":["5-20040-S1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vaccine.2019.04.066","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T08:36:39Z","timestamp":1559291799000},"page":"5535-5543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A\/H5N1 vaccines: A meta-analysis"],"prefix":"10.1016","volume":"37","author":[{"given":"W.A.","family":"Keitel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.C.","family":"Voronca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L.","family":"Atmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Paust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Bellamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.04.066_b0005","doi-asserted-by":"crossref","unstructured":"Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2017\u20132018 influenza season. MMWR Recomm Rep 2017; 66: p. 1\u201320.","DOI":"10.15585\/mmwr.rr6602a1"},{"key":"10.1016\/j.vaccine.2019.04.066_b0010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/14760584.2017.1334554","article-title":"Repeated annual influenza vaccination and vaccine effectiveness: Review of the evidence","volume":"16","author":"Belongia","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.066_b0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jama.2015.7916","article-title":"Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: A randomized clinical trial","volume":"314","author":"Jackson","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2019.04.066_b0020","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1016\/j.vaccine.2008.08.046","article-title":"Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children","volume":"26","author":"Nolan","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.066_b0025","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jama.2014.12854","article-title":"Serological responses to an avian influenza A\/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant. A randomized clinical trial","volume":"312","author":"Mulligan","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.066_b0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/infdis\/jis427","article-title":"Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons","volume":"206","author":"Jackson","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.066_b0035","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/infdis\/jiu284","article-title":"Responses to A(H1N1)pdm09 influenza vaccines in participants previously vaccinated with seasonal influenza vaccine: A randomized, observer-blind, controlled study","volume":"210","author":"Roy-Ghanta","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.066_b0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1348-0421.2011.00381.x","article-title":"Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: a randomized controlled trial","volume":"55","author":"Uno","year":"2011","journal-title":"Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.066_b0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2288-14-79","article-title":"Systematic review of methods for individual patient data meta-analysis with binary outcomes","volume":"14","author":"Thomas","year":"2014","journal-title":"BMC Med Res Method"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.066_b0050","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1541-0420.2009.01364.x","article-title":"Propensity score matching in randomized clinical trials","volume":"66","author":"Xu","year":"2010","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.066_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151724","article-title":"Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Propensity score-based approaches to confounding by indication in individual patient data meta-analysis: non-standardized treatment for multidrug resistant tuberculosis","volume":"11","author":"Fox","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.04.066_b0060","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/infdis\/jiq093","article-title":"Safety and immunogenicity of influenza A H5 subunit vaccines: Effect of vaccine schedule and antigenic variant","volume":"203","author":"Belshe","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.066_b0065","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1128\/CVI.00368-08","article-title":"Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure","volume":"16","author":"Noah","year":"2009","journal-title":"Clin Vacc Immunol"},{"key":"10.1016\/j.vaccine.2019.04.066_b0070","unstructured":"Guidance for Industry. Clinical data needed to support the licensure of pandemic influenza vaccines. https:\/\/www.fda.gov\/cber\/guidelines.htm."},{"key":"10.1016\/j.vaccine.2019.04.066_b0075","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/infdis\/jiv456","article-title":"Influence of statins on influenza vaccine response in elderly individuals","volume":"213","author":"Black","year":"2016","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.066_b0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"12","key":"10.1016\/j.vaccine.2019.04.066_b0085","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.066_b0090","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/sim.2580","article-title":"A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study","volume":"26","author":"Austin","year":"2007","journal-title":"Stat Med"},{"issue":"19","key":"10.1016\/j.vaccine.2019.04.066_b0095","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1002\/sim.5786","article-title":"Propensity score weighting with multilevel data","volume":"32","author":"Li","year":"2013","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.066_b0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1467-6419.2007.00527.x","article-title":"Some practical guidance for the implementation of propensity score matching","volume":"22","author":"Caliendo","year":"2008","journal-title":"J Econ Surveys"},{"key":"10.1016\/j.vaccine.2019.04.066_b0105","unstructured":"Lanehart RE, de Gil PR, Kim ES, Bellara AP, Kromrey JD, Lee RS. Propensity score analysis and assessment of propensity score approaches using SAS procedures. In: SAS Global Forum: Statistics and Data Analysis; 2012."},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.066_b0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivar Behav Res"},{"key":"10.1016\/j.vaccine.2019.04.066_b0115","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/527489","article-title":"Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults","volume":"197","author":"Bernstein","year":"2008","journal-title":"J Infect Dis"},{"issue":"13","key":"10.1016\/j.vaccine.2019.04.066_b0120","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.04.066_b0125","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1016\/j.vaccine.2009.10.152","article-title":"A phase I evaluation of inactivated influenza A\/H5N1 vaccine administered by the intradermal or the intramuscular route","volume":"28","author":"Patel","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.066_b0130","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1086\/592172","article-title":"Safety and immunogenicity of an inactivated influenza A\/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: Results of a phase I\u2014II randomized clinical trial","volume":"198","author":"Keitel","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.066_b0135","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2009.03.015","article-title":"Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A\/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults","volume":"27","author":"Keitel","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.066_b0140","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/infdis\/jis402","article-title":"Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes","volume":"206","author":"Patel","year":"2012","journal-title":"J Infect Dis"},{"issue":"59","key":"10.1016\/j.vaccine.2019.04.066_b0145","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/cid\/ciu680","article-title":"Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons","volume":"2014","author":"McLean","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.066_b0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12916-017-0919-0","article-title":"The impact of repeated vaccination on influenza vaccine effectiveness: A systematic review and meta-analysis","volume":"15","author":"Ramsay","year":"2017","journal-title":"BMC Medicine"},{"key":"10.1016\/j.vaccine.2019.04.066_b0155","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0264-410X(97)00003-0","article-title":"Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period","volume":"15","author":"Keitel","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.066_b0160","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1016\/j.vaccine.2018.04.049","article-title":"Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis","volume":"36","author":"Bartoszko","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.066_b0165","doi-asserted-by":"crossref","first-page":"14001","DOI":"10.1073\/pnas.96.24.14001","article-title":"Variable efficacy of repeated annual influenza vaccination","volume":"96","author":"Smith","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2019.04.066_b0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.vaccine.2012.10.039","article-title":"Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins","volume":"31","author":"Richards","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.066_b0175","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4049\/jimmunol.1203520","article-title":"Heterosubtypic influenza infection antagonizes elicitation of immunological reactivity to hemagglutinin","volume":"191","author":"Nayak","year":"2013","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.066_b0180","article-title":"Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection","volume":"12","author":"Alam","year":"2017","journal-title":"PLO One"},{"key":"10.1016\/j.vaccine.2019.04.066_b0185","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.vaccine.2011.01.039","article-title":"Evaluation of the safety, reactogenicity and immunogenicity of FluBlok\u00ae trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50\u201364 years of age","volume":"29","author":"Baxter","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.066_b0190","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/JVI.02371-10","article-title":"Vaccination against seasonal influenza A\/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A\/H5N1 virus infection in ferrets","volume":"85","author":"Bodewes","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.04.066_b0195","doi-asserted-by":"crossref","first-page":"11995","DOI":"10.1128\/JVI.05213-11","article-title":"Annual vaccination against influenza virus hampers development of virus-specific CD8+ T cell immunity in children","volume":"85","author":"Bodewes","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.04.066_b0200","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.192.8.1105","article-title":"T cells compete for access to antigen-bearing antigen-presenting cells","volume":"192","author":"Kedl","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2019.04.066_b0205","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1073\/pnas.0605130103","article-title":"CD8 T cell competition for dendritic cells in vivo is an early event in activation","volume":"103","author":"Willis","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2019.04.066_b0210","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1016\/j.vaccine.2007.04.015","article-title":"Validity of self-reported influenza an pneumococcal vaccination status among a cohort of hospitalized elderly inpatients","volume":"25","author":"Skull","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.066_b0215","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1016\/j.vaccine.2009.08.050","article-title":"Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort","volume":"27","author":"Irving","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.066_b0220","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/irv.12593","article-title":"Validation of self-reported influenza vaccination in the current and prior season","volume":"12","author":"King","year":"2018","journal-title":"Influenza Other Respir Viruses"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19305547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19305547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:31:27Z","timestamp":1778679087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19305547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":44,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0264410X19305547"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A\/H5N1 vaccines: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}